Kairos Pharma Wins 2025 R&D Award for Advanced Prostate Cancer
17 Dec 2025 //
BUSINESSWIRE
Kairos Presents on Ph 2 of ENV-105 in Advanced Prostate Cancer
20 Oct 2025 //
BUSINESSWIRE
Kairos Pharma Reports Positive Safety Results in ENV-105 Phase 2
15 Jul 2025 //
BUSINESSWIRE

Market Place
Sourcing Support